Objective: Mitochondrial dysfunction, oxidative stress and nucleus pulposus (NP) cell apoptosis are important contributors to the development and pathogenesis of intervertebral disc degeneration (IDD). Here, we comprehensively evaluated the effects of mitochondrial dynamics, mitophagic flux and Nrf2 signalling on the mitochondrial quality control, ROS production and NP cell survival in in vitro and ex vivo compression models of IDD and explored the effects of the mitochondria-targeted anti-oxidant MitoQ and its mechanism.
| INTRODUC TI ON
Intervertebral disc (IVD) degeneration (IDD) is widely acknowledged to be the primary cause of low back pain (LBP)-a chronic, expensive and common musculoskeletal disorder that is prevalent in developed and developing countries. 1 The IVD consists of three inter-related structures: the nucleus pulposus (NP), the annulus fibrosus (AF) and the cartilaginous endplate. The centrally situated NP allows the IVD to maintain a high water content and thereby withstand mechanical impact. 2 Excessive apoptosis of NP cells can trigger metabolic disorders within the NP extracellular matrix, resulting in the destruction of normal IVD structure and physiological function that eventually leads to IDD. 2, 3 Thus, determination of the key molecular mechanisms of NP cell apoptosis would be of great significance to the management of IDD.
The maintenance of a healthy and functional mitochondrial network is critical during development as well as for physiological adaptations and responses to stress in the body. 4, 5 Mitochondria are not only the main cellular source of reactive oxygen species (ROS), they are also particularly susceptible to oxidative injury. 6 Recently, studies have verified the presence of oxidative stress and increased concentrations of oxidation products in degenerated discs. [7] [8] [9] Additionally, oxidative stress and subsequent mitochondrial dysfunction participate in the intrinsic pathway of cellular apoptosis, which have been confirmed in NP cell death and IDD induced by various risk factors. [10] [11] [12] [13] [14] [15] Moreover, mitochondrial dysfunction induced by ROS can further enhance the production of ROS, leading to a feed-forward vicious cycle between mitochondria and ROS that causes sustained oxidative damage. 16 Thus, in addition to direct intervention targeting oxidative stress, the role of appropriate mitochondrial quality control in NP cell survival under pathological conditions is also worth studying.
Mitochondria are highly dynamic organelles that continuously undergo fission and fusion, known as mitochondrial dynamics. 17 The subtle equilibrium of mitochondrial dynamics is conducive to the maintenance of a healthy pool of mitochondria. 18 Destruction of this equilibrium is implicated in various human diseases including cancer, type 2 diabetes and osteoarthritis. 4, 19, 20 In addition to mitochondrial dynamics, the timely and selective removal of damaged mitochondria through an autophagic process termed mitophagy is important for maintaining mitochondrial quality. 5 Impairment of mitophagic flux results in the accumulation of dysfunctional mitochondria and ROS associated with various diseases. 21, 22 It has been shown that mitophagy and mitochondrial dynamics are inter-related yet distinct processes. During mitochondrial fission, the damaged daughter mitochondria are first separated then targeted by the lysosome for elimination, preventing damaged mitochondria from being incorporated back into the active and healthy mitochondrial pool via fusion. 4 The occurrence of oxidative stress caused by ROS overproduction is inseparable from anti-oxidant system defects. Nuclear factor E2-related factor 2 (Nrf2) is a key redox-sensitive transcription factor that regulates the anti-oxidant defence system by activating the expression of a number of cytoprotective genes in response to oxidative stress. 23 In addition, there is evidence that Nrf2 modulates mitochondrial function and metabolism. 24 Therefore, the present study investigated the maintenance of mitochondrial homeostasis via the simultaneous regulation of mitochondrial dynamics, mitophagy and Nrf2 signalling using a pharmacological method to rescues mitochondrial dysfunction and NP cell apoptosis under pathological conditions. Mitoquinone (MitoQ)-a mitochondria-targeted anti-oxidantconsists of co-enzyme Q10 and a TPP cation that can easily accumulate several 100-fold within the mitochondria, thereby making it more powerful than untargeted anti-oxidants in preventing mitochondrial oxidative damage. 25 In vitro and in vivo studies have demonstrated that MitoQ is protective against many oxidative damage-related diseases. [26] [27] [28] [29] [30] [31] [32] [33] In addition, daily oral doses of 40 or 80 mg MitoQ have been shown to protect against liver damage in hepatitis C patients 34 and can be safely administered to Parkinson's disease patients for up to 1 year. 35 There is evidence that the protective effect of MitoQ is partially mediated by the modulation of mitochondrial dynamics, mitophagy and Nrf2 signalling. 33, 36 These potential therapeutic benefits are encouraging and warrant further investigation of MitoQ as an intervention to prevent the development of IDD.
As a load-absorbing structure of the spine, the IVD is subjected to various magnitudes of mechanical compression throughout daily life. [37] [38] [39] Inappropriate or excessive compression applied to IVDs is an important contributing factor in causing IDD. 10, [40] [41] [42] [43] [44] Therefore, the in vitro and ex vivo models of IDD induced by compression are more in line with the pathogenesis of IDD. Studies have reported that ROS overproduction, mitochondrial dysfunction and apoptosis were induced by compression at a magnitude of 1.0 MPa in NP cells, all of which were closely related to IDD. 10, 11, 45, 46 Thus, we for the first time systematically investigated the changes in mitochondrial dynamics, mitophagy and Nrf2 signalling in human NP cells under 1.0 MPa compression. In addition, we studied the effect of MitoQ on human NP cells, as well as the roles of mitochondrial dynamics, mitophagy and Nrf2 signalling in the action of MitoQ. An ex vivo compression model of rat tail disc degeneration was used to confirm the results of the in vitro experiments. Our aim was to provide novel insights for the development of effective therapeutic strategies to inhibit IDD progression.
| MATERIAL AND ME THODS

| Tissue specimens and cell culture
This study was approved by the Ethics Committee of Tianjin Medical University General Hospital, and written informed consent was obtained from each donor. Nucleus pulposus specimens were collected from 10 IDD patients (6 males and 4 females, 41-69 years of age) suffering from cervical spondylotic myelopathy who received anterior cervical discectomy and fusion at Tianjin Medical University General Hospital. Nucleus pulposus cell isolation and culture were carried out as previously described. 47 During passaging, no significant changes in morphology were observed between primary (passage 0) and later-passage (passage 2) cells.
Therefore, we used second-passage cells cultured in a monolayer for experiments.
| Establishment of ex vivo organ culture of IVD
IVDs were collected from Sprague Dawley rats (3 months old) with the ethical approval of the Animal Care and Use Committee of Tianjin Medical University. The intact caudal discs with complete endplates were isolated and cultured in DMEM containing 15% foetal bovine serum (Gibco) and 1% penicillin/streptomycin (Invitrogen) as previously described. 48 
| Compression treatment
IVD organs or NP cells were exposed to continuous high pressure in a previously described compression apparatus. 10, 48 In brief, the tissues or cells were placed in cell culture plates on the bottom of the compression apparatus, which contained a small amount of distilled water to maintain the moisture level. The compression apparatus was placed in an incubator at 37°C. A mixture of 0.5% CO 2 and 99.5% compressed air was pumped into the apparatus until the pressure reached 1.0 MPa. The control group samples were incubated at 37°C without any compression under the same culture conditions.
| Cell viability assay
According to the manufacturer's instructions, the cytotoxic effect of compression on human NP cells was assessed using a cell counting kit (CCK-8; Dojindo). Briefly, the cells were seeded in 96-well plates and treated with MitoQ or compression. Subsequently, the cells were incubated with 10 μL CCK-8 solution at 37°C for 2 hours. The absorbance at 450 nm was measured using a spectrophotometer (BioTek). 
| Western blotting
After cell treatments, total, cytoplasmic and mitochondrial proteins from NP cells were extracted using commercial kits (Beyotime) according to the manufacturer's instructions. Protein concentrations were determined with a BCA Protein Assay Kit (Beyotime). Equal amounts of protein from each sample were separated using SDS-PAGE and transferred to PVDF membranes. The membranes were blocked with 7.5% non-fat milk for 1 hour and then incubated at 
| Short interfering (si)RNA transfection
SiRNAs against PINK1 (siPINK1) (5′-GCUAGUUACAAGAGAACAA-3′), Parkin (siPar- kin) (5′-GAAUACAUUCCCUACCUCA-3′), Nrf2(siNrf2)
| Flow cytometry
Apoptosis levels, ΔΨm changes, mPTP opening, cellular ROS production and mitochondrial ROS production in human NP cells from each treatment group were assessed using an Annexin V-APC/7-AAD Apoptosis Detection Kit (Yeasen), JC-1 Assay Kit (Beyotime), mPTP Assay Kit (Yeasen), DCFH-DA (Beyotime) and MitoSOX Red (Invitrogen), respectively, as previously described. 15 After labelling, samples were examined using a FACSCalibur flow cytometer (BD Biosciences).
| Measurement of malondialdehyde (MDA) levels
MDA levels were measured using assay kits for MDA (Beyotime) as per manufacturer's instructions.
| Immunofluorescence
Immunofluorescence staining of human NP cells was conducted as described previously. 49 The cells were incubated with primary antibodies against Tom20 (mitochondrial antibody) (ab186734, Abcam), Drp1 (ab56788, Abcam), Parkin (ab77924, Abcam), LC3
(#12741, Cell Signaling Technology), LAMP1 (lysosomal antibody) (ab25630, Abcam) and Nrf2 (ab137550, Abcam) at 4°C overnight and then with appropriate secondary antibodies at room temperature for 1 hour. Nuclei were stained with DAPI (ZSGB-BIO).
Fluorescence images were acquired using a laser-scanning confocal microscope (FV1000; Olympus) or confocal laser-scanning microscope (LSM800; Zeiss).
| mRFP-GFP-LC3 assay
Human NP cells were infected with mRFP-GFP-LC3 adenoviral vec-
tors (HanBio Technology) to evaluate the effects of compression
and MitoQ on mitophagic flux. The principle of the assay is based on differences in pH stability between the green and red fluorescent proteins. The mRFP and GFP puncta in each treatment group were detected using a laser-scanning confocal microscope (FV1000;
Olympus).
| Measurement of cathepsin B (CTSB) activity, cathepsin D (CTSD) activity and lysosomal pH changes
CTSB and CTSD activities were measured using specific fluorometric assay kits for the two enzymes (BioVision) as described previously. 50 Changes in lysosomal pH were determined using LysoSensor Green DND-189 (Yeasen) as described previously 51 ; this reagent exhibits a pH-dependent increase in fluorescence intensity in acidic environments.
| Assessments of IVD ex vivo compression model
The rat disc tissues from each group were harvested. The specimens were fixed in formaldehyde, decalcified, dehydrated, embedded in paraffin and sectioned at a thickness of 4 μm. The sections were stained with haematoxylin and eosin (HE) and
safranin O-fast green (SO), and the histological grades of the specimens were determined to quantify damage based on a previously described method. 52 For TUNEL staining, the sections were handled using a TUNEL Apoptosis Assay Kit (Beyotime) and samples were imaged with a fluorescence microscope (Olympus IX71). Immunohistochemistry was performed as described previously. 53 For immunohistochemical analysis, sections were incubated with primary antibodies against cleaved 
| Statistical analysis
Data are presented as the mean ± standard deviation (SD) of at least three independent experiments and were analysed using SPSS version 18.0 software (SPSS Inc, Chicago, IL, USA). Differences between groups were evaluated using Student's t test or one-way analysis of variance (ANOVA) followed by Tukey's test. P < .05 was considered statistically significant.
| RE SULTS
| Effects of MitoQ on compression-induced cytotoxicity in human NP cells
Compression was used to establish an IDD model in vitro. As shown in Figure 1A 
| Effects of MitoQ on compression-induced ROS accumulation, mitochondrial dysfunction and apoptosis in human NP cells
Next, we investigated whether MitoQ protects NP cells from compression-induced damage. The results showed that compression treatment significantly increased intracellular and mitochondrial
ROS production in human NP cells and that this was inhibited by
MitoQ (Figure 2A -D). MDA levels in human NP cells were markedly increased after exposure to compression ( Figure 2E ). MitoQ largely suppressed the elevation in MDA levels induced by compression ( Figure 2E ). Flow cytometric analysis indicated that excessive mitochondrial ROS production was accompanied by increased mPTP opening ( Figure 2F ) and decreased ΔΨm ( Figure 2G ,H) in human NP cells exposed to compression. However, this alteration was largely abolished by MitoQ ( Figure 2F 
| Effects of MitoQ on compression-induced alterations in mitochondrial dynamics in human NP cells
Migration of Drp1 from the cytoplasm to mitochondria is a pre-requisite for mitochondrial fission. As shown in Figure 3A 
| Effects of MitoQ-maintained mitochondrial dynamics balance on compression-induced damage in human NP cells
We next investigated whether these beneficial effects of MitoQ are 
| Effects of MitoQ on PINK1/Parkin-mediated damaged mitochondrial clearance in human NP cells exposed to compression
We first investigated whether the PINK1/Parkin signalling pathway was activated in human NP cells exposed to compression. Western blot results showed that the total protein expression of PINK1 and Parkin increased after compression treatment ( Figure 5A-C Tom20 in human NP cells revealed an elevated colocalization of Parkin and Tom20 in compression-exposed cells compared to control cells ( Figure 5G,H) . Next, we assessed the effect of compression in the next step of mitophagy, the engulfment of mitochondria by autophagosomes.
The immunofluorescence results showed that compression treatment promoted colocalization of LC3 and Tom20 (Figure 5I,J) . Moreover, Western blot analysis indicated that the protein level of mitochondrial LC3-II was increased in compression-exposed cells compared with control cells (Figure 5K,L) . These results suggested that compression activates PINK1/Parkin pathway-mediated mitophagy.
Dysfunctional mitochondria are delivered to lysosomes for degradation following their engulfment in autophagosomes, a process that requires undamaged mitophagic flux. Western blot results indicated that compression treatment markedly increased the p62 protein level, but did not decrease the LC3-II/I ratio and Beclin-1 protein level ( Figure 6A,B) . This finding was confirmed by transfection of a tandem mRFP-GFP-LC3 construct into human NP cells. As compared with the control group, the compression group showed an increase in yellow but not red puncta ( Figure 6C,D) . These data suggested that the mitophagic flux was impaired in compression-exposed human NP cells.
Next, we explored the mechanism underlying mitophagic flux blockade by compression. The activities of CTSB and CTSD-key proteases that degrade trapped cargo in lysosomes-were measured to evaluate lysosomal degradation ability in the treated human NP cells. As shown in Figure 6E ,F, compression decreased the activity levels of both enzymes. Low lysosomal pH is required for the maturation and activation of most lysosomal enzymes; thus, we measured the lysosomal pH by LysoSensor Green DND-189 staining. As shown in Figure 6G , compression treatment induced an obvious decrease in fluorescence intensity.
Further, we investigated mitophagosome-lysosome fusion based on LC3-LAMP1 colocalization. Compression led to a significant decrease in LC3-LAMP1 colocalization when compared to the control groups ( Figure 6H ,I). The colocalization of Tom20 and LAMP1 was decreased in compression-exposed cells compared to control cells ( Figure 6J,K) , suggesting that dysfunctional mitochondria engulfed in mitophagosomes would not be able to enter lysosomes in compression-exposed human NP cells. These data suggested that compression impairs lysosomal function and mitophagosome-lysosome fusion. ( Figure 6E-K) . Collectively, these findings suggested that MitoQ promotes PINK1/Parkin-mediated mitophagy and repairs defective mitophagy flux in human NP cells exposed to compression.
| Role of mitophagic flux in the beneficial effects of MitoQ on compression-exposed human NP cells
Then, we knocked down PINK1 and Parkin using siRNAs to interfere with mitophagy activation. As shown in Figure 7A 
| Effects of MitoQ on the Nrf2 pathway in compression-exposed human NP cells
The above results indicated that MitoQ markedly alleviated the oxidative stress induced by compression in human NP cells.
Therefore, it was reasonable to assume that the effect of MitoQ Further, we measured the activity of Nrf2 signalling in human NP cells exposed to compression and treated with MitoQ. As shown in Figure 8L -V, compression increased the protein expression of Nrf2 and its downstream targets and the nuclear translocation of Nrf2.
MitoQ treatment further increased the activity of Nrf2 pathway in compression-treated human NP cells ( Figure 8L-V) . Overall, these findings suggested that MitoQ can activate the Nrf2 signalling pathway in compression-exposed human NP cells.
| Role of Nrf2 signalling in MitoQ-mediated anti-oxidative stress and anti-mitochondrial disorder in compression-exposed human NP cells
To determine whether and how Nrf2 mediates the protective effects of MitoQ on human NP cells under compression, we specifically knocked down Nrf2 in human NP cells followed by MitoQ treatment and compression exposure. Western blot results showed that transfection with siNrf2 led to a significant decrease in the protein levels of Nrf2 and its downstream anti-oxidant factors (Figure 9A,B) . 
| MitoQ ameliorates IDD development in an ex vivo model
To further confirm the findings of these in vitro experiments, we in- Figure 10A ). With MitoQ treatment, these degenerative changes of the disc structure were alleviated ( Figure 10A ).
Histological scores also indicated that MitoQ protected against IDD development ( Figure 10B ). The results of TUNEL staining in IVD specimens from rats revealed that the apoptosis rate was de- Immunohistochemical staining results for cleaved caspase-3, Drp1, Mfn2, Parkin, LC3, p62 and Nrf2 were consistent with the Western blotting results ( Figure S3 ). Together, these findings suggested that MitoQ ameliorates IDD progression in an ex vivo model, likely by improving mitochondrial dynamics, mitophagic flux and Nrf2 signalling.
| D ISCUSS I ON
In this study, we constructed the IDD model induced by compression and found that compression leads to mitochondrial dysfunction, oxidative stress and apoptosis in human NP cells. MitoQ is a mitochondria-targeted anti-oxidant that has therapeutic effects in numerous mitochondria-related diseases. Therefore, we used
MitoQ as a stabilizer of mitochondrial function to treat compression-exposed human NP cells in this study. We found that MitoQ Under normal physiological conditions, mitochondria undergo morphological changes to meet cellular energy requirements.
These changes can occur through sustained fusion and fission.
Excessive mitochondrial fission leads to fragmentation of mitochondria, resulting in mitochondrial dysfunction and ultimately cell death. 58 Parkin results in the accumulation of dysfunctional mitochondria that release ROS, thereby increasing the oxidative stress that is involved in the pathogenesis of several diseases. [61] [62] [63] We found that PINK1 and Parkin protein levels and mitochondrial Parkin translocation were increased in human NP cells upon compression, which was accompanied by increased colocalization of LC3 and Tom20, indicating mitophagy initiation. However, after deeper investigation, we found that the protein level of p62 was remarkably upregulated and lysosomal quenching of GFP fluorescence was compromised,
indicating that compression impaired mitophagic flux. Damaged mitochondria are engulfed by autophagosomes to form mitophagosomes, which are fused with lysosomes to form mitolysosomes,
where damaged mitochondria are degraded by hydrolases. 4, 64 As such, disturbed lysosomal function or impaired mitophagosome-lysosome fusion can alter mitophagic flux outcomes. 6 Here, we found that mitophagic flux blockade resulted from impairments in mitophagosome-lysosome fusion and lysosomal degradation ability in compression-exposed human NP cells. Additionally, we found that MitoQ further promoted PINK1/Parkin-mediated mitophagy and restored mitophagic flux. Moreover, in human NP cells exposed to compression and treated with MitoQ, knockdown of Parkin or PINK1 or CQ treatment sensitized NP cells to compression-induced apoptosis, which was largely due to the inhibition of mitophagy initiation or obstruction of mitophagic flux. Our data thus provide evidence that activation of PINK1/Parkin-mediated mitophagy combined with the enhancement of mitophagic flux is critical for human NP cell survival.
Mitochondrial dynamics and mitophagy serve as co-ordinated quality-control mechanisms for maintaining a healthy mitochondrial population. When mitochondria are damaged by pathological stimuli, they can fuse with healthy mitochondria to produce larger damaged mitochondria, which exacerbate the damage by releasing high levels of ROS. 4 In this sense, co-ordination of mitochondrial dynamics and mitophagy is very important. After the cell separates the damaged mitochondrial region through mitochondrial fission, there are two sets of daughter mitochondria that either have increased membrane potential (presumably high-quality mitochondria) or have decreased membrane potential (presumably low-quality mitochondria). Timely and effective clearance of low-quality mitochondria via mitophagy contributes to the preservation of high-quality mitochondria. 4, [65] [66] [67] [68] In compression-exposed human NP cells, mitochondrial fission is activated and mitophagic flux is blocked, which leads to the accumulation of damaged mitochondria, resulting in mitochondrial homeostatic imbalance and apoptosis. We used MitoQ to maintain the balance of mitochondrial dynamics and relieve the blockage of mitophagic flux, which reversed mitochondrial dysfunction and NP cell apoptosis.
Oxidative stress is closely associated with inadequate activation of the anti-oxidant system. 23, 69 Under resting conditions, Keap1 binds to cytosolic Nrf2, promoting continual ubiquitination and proteasomal degradation of Nrf2 through a Cul3-ubiquitin ligase complex. Upon dissociated from Keap1, Nrf2 is translocated into the nucleus and then initiates cytoprotective gene transcription to counteract oxidative stress and modulate redox status balance. 23 In keeping with this, the Nrf2-activating drug dimethyl fumarate has been approved by the FDA for the treatment of multiple sclerosis, 70 in part based on its anti-oxidative effects. Further, Nrf2 plays an important role in maintaining mitochondrial homeostasis by affecting the ΔΨm, respiration, oxidative phosphorylation, ATP synthesis, mitochondrial biogenesis and mitochondrial integrity. 24, 71, 72 Here, we observed increases in the activity of Nrf2 pathway in human NP cells upon compression, reflecting the NP cellular response to the induced oxidative stress.
However, this increase in Nrf2 signalling activity was not sufficient to counteract the pathogenic events induced by oxidative stress in compression-exposed human NP cells. Moreover, MitoQ further promoted Nrf2 expression and activity in human NP cells exposed to compression. siRNA-mediated depletion of Nrf2 and HO-1 partially inhibited the protective actions of MitoQ on compression-induced oxidative stress, mitochondrial impairment and apoptosis. These results suggest that the beneficial effects of MitoQ on compression-exposed human NP cells are partially attributed to the upregulation of Nrf2 expression and activity.
